Evaluation of mechanical device collection of nasal virus

Nosebrush Corporation is a start-up innovation medical device group with a Scientific Inventor, CEO, CFO, and legal advisor. The scientific advisor is an Associate Professor at the University of Toronto and has independently worked on this device with association to the H2i Innovation Hub. Viruses linger in the nose before infecting the body. The team has developed a Class 1 mechanical device (patent pending) with Health Canada approval of the claim that the device can collect virus from the nasal cavity, for the purpose of removal toward illness reduction. The device is approved for the collection of coronaviruses, influenza, RSV, and common cold virus from the nasal cavity. Lower viral load will lead to less illness. The challenge is to develop a framework for identifying the target population, evaluating their needs, and creating prospective research projects to answer those needs. The research projects will aim to solve specific questions such as user, usability, safety, and efficacy. The Nosebrush device aims to empower individuals to take control over their health, by enabling them to seek preventative measures upon exposure to viruses. The Nosebrush device will decrease the impact of viral illness in the population by reducing work-place loss and morbidity, thereby increasing quality of life.

Faculty Supervisor:

Joseph Ferenbok

Student:

Partner:

Nosebrush

Discipline:

Life Sciences

Sector:

Manufacturing

University:

University of Toronto

Program: